Engineered reversal of drug resistance in cancer cells--metastases suppressor factors as change agents

EMT is the dominant program in human colon cancer

(2013) Andre Loboda et al.   BMC Medical Genomics

Recent advances in pathway-targeted cancer drug therapies emerging from cancer genome analysis

(2012) Robert L Yauch et al.   CURRENT OPINION IN GENETICS & DEVELOPMENT

Systematic identification of genomic markers of drug sensitivity in cancer cells

(2012) Mathew J. Garnett et al.   NATURE

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

(2012) Jordi Barretina et al.   NATURE

Using transcriptome sequencing to identify mechanisms of drug action and resistance

(2012) Sarah A Wacker et al.   Nature Chemical Biology

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer

(2011) Christos Hatzis   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Development of Resistance towards Artesunate in MDA-MB-231 Human Breast Cancer Cells

(2011) Beatrice Bachmeier et al.   PLoS One

Transcription factors that mediate epithelial–mesenchymal transition lead to multidrug resistance by upregulating ABC transporters

(2011) M Saxena et al.   Cell Death & Disease

A genomic and transcriptomic approach for a differential diagnosis between primary and secondary ovarian carcinomas in patients with a previous history of breast cancer

(2010) Jean-Philippe Meyniel et al.   BMC CANCER

Tetrandrine Inhibits Wnt/ -Catenin Signaling and Suppresses Tumor Growth of Human Colorectal Cancer

(2010) B.-C. He et al.   MOLECULAR PHARMACOLOGY

DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs

(2010) C. Knox et al.   NUCLEIC ACIDS RESEARCH

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer

(2010) A Singh et al.   ONCOGENE

Discovery of drug mode of action and drug repositioning from transcriptional responses

(2010) F. Iorio et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

RECK Negatively Regulates Matrix Metalloproteinase-9 Transcription

(2009) Satoshi Takagi et al.   CANCER RESEARCH

Epithelial-Mesenchymal Transitions in Development and Disease

(2009) Jean Paul Thiery et al.   CELL

Experimentally Derived Metastasis Gene Expression Profile Predicts Recurrence and Death in Patients With Colon Cancer

(2009) J. Joshua Smith et al.   GASTROENTEROLOGY

A prognostic gene expression index in ovarian cancer-validation across different independent data sets

(2009) Carsten Denkert et al.   JOURNAL OF PATHOLOGY

Revealing Global Regulatory Perturbations across Human Cancers

(2009) Hani Goodarzi et al.   MOLECULAR CELL

The role of metastasis suppressor genes in metastatic dormancy 

(2008) CHRISTINE E. HORAK et al.   APMIS

Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancer

(2008) Alberto Calabrò et al.   BREAST CANCER RESEARCH AND TREATMENT

ABCG2 Expression and Side Population Abundance Regulated by a Transforming Growth Factor  -Directed Epithelial-Mesenchymal Transition

(2008) L. Yin et al.   CANCER RESEARCH

Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome

(2008) R. W. Tothill et al.   CLINICAL CANCER RESEARCH

A modular approach for integrative analysis of large-scale gene-expression and drug-response data

(2008) Zoltán Kutalik et al.   NATURE BIOTECHNOLOGY

Gene Expression Signature of Cigarette Smoking and Its Role in Lung Adenocarcinoma Development and Survival

(2008) Maria Teresa Landi et al.   PLoS One